Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Chelsea Therapeutics International Ltd.    CHTP

No quotes available
-- USD   0.00%
2014 Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHE..
2014 CHELSEA THERAPE : Shareholder Alert: Former SEC Attorney Willie Bris..
2014 CHELSEA THERAPE : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces ..
 SummaryQuotesNewsCalendarCompanyFinancials 
Company
Chelsea Therapeutics International Ltd. is a development stage biopharmaceutical company, which seeks to acquires, develops and commercializes innovative products for the treatment of a variety of human diseases, including central nervous system disorders.The company product includes... 
More about the company
Latest news on CHELSEA THERAPEUTICS INTER
2014 Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at Intern..
2014 CHELSEA THERAPEUTICS : Shareholder Alert: Former SEC Attorney Willie Briscoe and..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investi..
2014 CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
2014 CHELSEA THERAPEUTICS : Newman Ferrara LLP : Announces Investigation of Chelsea T..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Brower Piven Announces the Investigati..
2014 CHELSEA THERAPEUTICS : Law Firm Kirby McInerney LLP Investigating Potential Clai..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Inves..
2014 CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
2014 Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day
More news
Sector news : Bio Therapeutic Drugs
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
More sector news : Bio Therapeutic Drugs
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Staffan Schüberg President & Director
Julie Hakim Secretary, Treasurer & Director
Joseph Nolan Director
Timothy L. Maness Senior Director-Finance & Controller
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CHELSEA THERAPEUTICS I..0.00%0
AMGEN, INC.5.94%128 696
GILEAD SCIENCES, INC.-21.17%105 269
CELGENE CORPORATION-9.16%84 325
REGENERON PHARMACEUTIC..-25.77%42 431
VERTEX PHARMACEUTICALS..-22.84%24 057
More Results